Demographics, endovascular treatments, and outcomes of treatment group
| Demographics | |
|---|---|
| Gender | 10 men, 4 women |
| Mean age (ys) ± SD | 58 ± 14 |
| Median baseline NIHSS (range) | 17 (11–25) |
| Mean time (min) from stroke onset to endovascular therapy ±SD | 389 ± 103 |
| Thrombolytics | 9 IV/IA, 3 IA, 1 IV, 1 none |
| Mean total IA dose ± SD | Reteplase (n=8): 3 ± 1.2 mg (median 3 mg, range 1–4.9 mg) |
| Urokinase (n=2): 250,000–650,000 U | |
| rtPA (n=2): 4–19 mg | |
| Occlusion location | 8 left, 6 right |
| Occlusion type | 4 type II, 10 type III |
| Adjunctive therapy | 2 simple mechanical, 5 angioplasty, 6 angioplasty/stenting |
| Immediate recanalization (TICI ≥ 2) | 64% |
| Decrease in expected infarct volume | 50% |
| ASPECT scores | Mean 4 ± 2.9, median 3, range 0–8, 21% ≥ 8 |
| Symptomatic hemorrhage | 7% |
| Mortality | 21% |
| Favorable outcome (discharge home or inpatient rehabilitation) | 64% |
Note.—NIHSS indicates National Institutes of Health Stroke Scale; IA, intraarterial; IV, intravenous; TICI, thrombolysis in cerebral infarction; ASPECT, Alberta Stroke Program Early CT.